Proposed study focuses on Youth With HIV (YWH) recruited from the University of North Carolina using a cross sectional assessment of blood samples, clinical, demographic, behavioral, \[including substance use and frequency\], and neurocognitive data will be evaluated from YWH treated before CD4 T cell decline.
Age range
21 Years – 28 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of bio-marker pathways that are abnormal.
Timeframe: 24 months
Plasma levels of sCD163
Timeframe: 24 months
Neurocognitive function as measured by Trial Making Test (TMT)
Timeframe: 24 months
Neurocognitive function as measured by WAIS-III (5 subtest IQ estimate)
Timeframe: 24 months
Neurocognitive function as measured by Hopkins Verbal Learning Test-R
Timeframe: 24 months
Neurocognitive function as measured by the Brief Visuospatial Memory Test-R
Timeframe: 24 months
Neurocognitive function as measured by the WRAT-4 Word Reading subtest
Timeframe: 24 months
Neurocognitive function as measured by Activities of Daily Living Questionnaire
Timeframe: 24 months
Neurocognitive function as measured by Behavior Rating Inventory of Executive Functioning
Timeframe: 24 months
Neurocognitive function as measured by Grooved Pegboard test
Timeframe: 24 months
Neurocognitive function as measured by Timed Gait Test
Timeframe: 24 months
Neurocognitive function as measured by Verbal Fluency Test
Timeframe: 24 Months
Neurocognitive function as measured by Brief Symptom Inventory
Timeframe: 24 months
Neurocognitive function as measured by Beck Depression Inventory-II
Timeframe: 24 months
Neurocognitive function as measured by ASSIST (substance abuse)
Timeframe: 24 months
Neurocognitive function as measured by Base ATN Adherence Questions
Timeframe: 24 months